The impact of myopia on quality of life
The effects of myopia on visual function and the long-term risks of ocular health complications are well-documented.1 Yet the influence myopia can have on quality of life and psychosocial functioning is often overlooked. As an increasing number of children and adolescents develop myopia,2 it is important to consider all of the burdens associated with myopia […]
COVID-19 and the myopia epidemic
Globally, myopia impacts every 1 in 3 people, on average, and its prevalence is expected to continue to increase. It is projected that 50% of the world’s population will be myopic by 2050.¹ In 2020, as the world went into lockdown, concerns were raised about the potential for home confinement during the COVID-19 pandemic to […]
Dopavision Closes €12 Million Series A Round to Advance Digital Childhood Myopia Therapeutic Through Clinical Trials
– Seventure Partners and Novartis Pharmaceuticals join as new investors – Transformative treatment for millions of children with myopia Berlin, Germany, July 14, 2021 — Dopavision, a company pioneering the development of digital therapeutics, today announced the closing of a €12 million Series A financing round. Seventure Partners led the round and was joined by […]
Dopavision presents new research at ARVO virtual conference
Dopavision is presenting its new research findings at the ARVO conference, which is held virtually this year. The ARVO conference is the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) and one of the largest research conferences in vision world-wide, gathering key opinion leaders and experts in ophthalmology and myopia from […]
Dopavision featured in German TV magazine 3sat NANO
Dopavision was featured in today’s edition of the TV science program NANO by German TV station 3sat. For some time, scientists have observed that myopia is increasing at an unprecedented rate. New evidence shows that changes in visual behavior at work, school and during leisure time are driving the increase in myopia. This trend is […]
Dopavision’s Tim Schilling to present at myopia webinights online seminar
Tim Schilling will present today in the virtual Myopia Webinights format on the state of research on the role of dopamine in myopia. Myopia Webinights is a series of online talks on the science around myopia, intervention possibilities, and managing myopia in daily clinical care. It is directed at scientists, ophthalmologists and optometrists, regularly draws […]